ReviewFuture journal of pharmaceutical sciences2022

Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies.

Chinonyerem O Iheanacho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.